The permeability of the blood-brain barrier to noradrenaline was estimated in rats with bile duct li gation by intracarotid injection of [14Cl-L-noradrenaline, 3H20, and [ll3mInjethylene diamine tetraacetate (EDTA) under pentobarbitone anaesthesia, Brain uptake of [14Clnoradrenaline was expressed as a percentage of that of 3H20 (brain uptake index, B UI) and corrected for the "blood background" by the 113mIn. The BUI of noradren aline (1.20 ± 0.19) was not increased in jaundice (0.78 ± 0.18). The capacity of oxygenated homogenates of rat
Cerebral blood flow is not normally very sensitive to intravascular noradrenaline (Olesen, 1972) . This is considered to be due to the inaccessibility of the arteriolar smooth muscle rather than to a lack of receptors, since cerebral vasoconstriction can be induced by microinjection of noradrenaline into the perivascular space of pial arteries (Wahl et aI., 1972) or into the interstitial fluid of the hypothalamus (Cranston and Rosendorff, 1971 ). On the other hand, intravascular administration, when the cere bral endothelium has been opened by osmotic shock, has caused an increase in cerebral blood flow, probably secondary to an increase in cerebral metabolic rate (Mackenzie et aI., 1976) .
A moderate reduction in cerebral blood flow was found with intracarotid infusion of noradrenaline (8 or 16 j.Lg min -1 ) in baboons with bile duct ligation (Bloom et aI., 1975) . It was suggested that this hy persensitivity to noradrenaline might be due to an brain to remove noradrenaline was measured. The pres ence of jaundiced plasma always caused a substantial suppression of noradrenaline removal. No effect of jaun dice on specific radioactive assays for catechol-O-methyl transferase (COMT) or monoamine oxidase (MAO) could be demonstrated. Key Words: Blood-brain barrier-Ca techol-O-methyl transferase-Monoamine oxidase Noradrenaline-Obstructive jaundice-Uptake mecha nisms for noradrenaline.
inhibition of the uptake-2 mechanism for noradren aline, since a similar pattern was produced by ca techol-O-methyl transferase (COMT) inhibition (McCalden and Eidelman, 1976) . Other possible ex planations include increased passage of noradren aline through the cerebral endothelium or inhibition of any of the transport and metabolic mechanisms contributing to the removal of noradrenaline from the cerebral interstitial fluid. These mechanisms in clude the neuronal uptake-l transport process and deamination by monoamine oxidase (MAO) en zymes, in addition to the extraneuronal uptake-2 transport process and transmethylation by COMT. To investigate the problem further, we tested the blood-brain barrier permeability to noradrenaline in experimental jaundice and estimated noradrena line uptake and metabolism by homogenates of brain in the presence of jaundiced plasma.
METHODS

Ligation of bile duct
Male rats of the Wistar-Porton strain, weighing 200-300 g, were anaesthetized by ether inhalation. The ab domen was opened and the bile duct identified. This was ligated with at least three separate ties, close to the liver. Entry of pancreatic ducts into the bile duct distally thus was not impaired. An intravascular injection of 5 x 105 U of pencillin G was given postoperatively. The animals were maintained with free access to water and normal laboratory chow for 5-8 days, at which time the total bilirubin in blood plasma was estimated by the Unitest® system (Bio-Dynamics). In 32 jaundiced rats this was 6.61 ± 1.17 mg dl-I (mean ± SE), and in 5 controls, 0.30 ± 0.08 mg dl-I. No difference was apparent between the biliru?in conce � trations . in rats from the different groups used III the vanous studies described below.
Measurement of brain uptake index
The technique of intracarotid injection and analysis of brain uptake index (BUI) for [I4C]noradrenaline was that of Oldendorf and Szabo (1976) . Briefly, control and jaun diced rats were alternately anaesthetized by the i.p. in jection of sodium pentobarbitone. The right common ca rotid was surgically exposed and a 27-gauge needle (ex terior diameter, 0.38 mm) was inserted. A 0.2-ml bolus of Ringer solution, containing radiotracers and buffered to pH 7.55, was rapidly injected. Each injectate contained -0.5 /LCi of L-[8-14C]noradrenaline D-bitartrate (Radio chemical Centre, Amersham), 1 /LCi of 3H20, and 50 /LCi of [113mIn]ethylene diamine tetraacetate (EDTA). The conc � ntration of noradrenaline was -0.2 mM. The Ringer solutIOn had the)onic composition of cerebrospinal fluid (Bradbury and Stulcova, 1970) , except that it was buff ered to 7.55 with 4 mM HEPES (N-2-hydroxyethylpiper azine-N'-2-ethanesulphonic acid) and contained no bicar bonate. The [I13In]EDTA stock solution was prepared from the HCl eluate from a [II3Sn] generator (Radiochem ical Centre); the HCl was neutralized with NaHC0 3 and dis odium EDTA was added as described by Oldendorf and Szabo (1976) . The rat was decapitated 10 s after the intracarotid injection, and the cerebral hemisphere ipsi lateral to the injection was rapidly removed. The brain was homogenized by pushing it back and forth between two syringes joined by a polythene connector. Three 0.1ml aliquots for each brain were 'injected' into tared counting vials. One millilliter of Soluene (Packard) was added to each brain sample, which was immediately counted in a Nuclear Enterprises automatic gamma counter, the window being set to receive the maximum of I13mIn radiation. Elapsed time was also recorded. After gamma counting and complete solution of the brains in Soluene, the samples were mixed with an organic scin tillator in preparation for routine scintillation counting when all the I13mIn had effectively decayed (48 h). Ali quots of a diluted injectate were similarly counted in the presence of 0.1 ml of homogenized brain from a nonin jected rat, to make quenching uniform.
The activities due to 3H and 14C were determined in a Packard Tr icarb® liquid scintillation spectrometer; quench corrections and separation of activities due to two isotopes were performed by reference to quench and crossover curves for pure standards, plotted against counts from an external standards. The 14C-to_3H ratio in brain divided by the same ratio in the injectate when di vided by 100, gives the BUI. Similarly, the 113mIn_to_3H ratio gives a 'background' BUI which allows for isotope containing blood left in the tissue. Hence, the difference between the two indices gives a corrected Bur for nor adrenaline:
Noradrenaline BUr (corrected)
Removal of noradrenaline by brain homogenates
Pairs of rats, control and jaundiced, were anaesthetized with ether, and as much blood as possible was removed by external jugular puncture into heparinized syringes. The cerebral hemispheres from each rat were rapidly re moved, weighed, and lightly homogenized at 4°C in 5.0 ml 100 mM sodium phosphate buffer, pH 7.80, containing 10 mM MgCI2• The buffer was maintained saturated with O2; the homogenization entailed 20 up-and-down strokes with a Te flon plunger and rotation of the buffer in a glass tube at 300 rpm (clearance, 0.25 mm). Two milliliters of brain homogenate and 2 ml of plasma at 37"C were trans ferred to a chamber, also maintained at 37°C, where they were continually mixed with a magnetic stirrer and were in contact with an atmosphere of 100% O2, Once the ho mogenate-plasma mix had reached 37°C, 4 /Lg of L-nor � drenaline bitartrate (Sigma) in 20 /Ll 0.9% NaCl was rap Idly added. Thereafter, 500-/Ll aliquots of the mix were removed into small conical tubes for separation of super natant from cellular material (centrifugation at 8,000 g for 1 min) at intervals such that each centrifugation began at a fixed time. After each centrifugation, 0.2 ml of super natant was added to 0.2 ml 1 M perchloric acid. After mixing and a second centrifugation, the supernatant in perchloric acid was neutralized with NaOH and its nor adrenaline content was analyzed fluorimetrically in du plicate by the method of Von Euler and Floding (1955) as improved by Von Euler and Lishajko (1961) . These ex periments were arranged so that two homogenates were always incubated simultaneously with noradrenaline. One always contained normal brain and normal plasma and acted as a control. The other contained either jaun diced brain and jaundiced plasma, normal brain and jaun diced plasma, or jaundiced brain and normal plasma. This allowed statistical comparison of the results by a paired t test.
Assay of COMT and MAO activities
For these two assays, blood plasma and brains were removed and homogenized as above, except that -0.1 g of brain (after syringe mixing) was homogenized with 2.0 ml of plasma instead of with buffer. Brain homogenate (30 /Ll) in plasma was taken and assayed for COMT ac tivity by the method of McCaman (1965) . This involved methylation of 3,4-dihydroxybenzoic acid by S-adenosyl L-[methyl-14C]-methionine (Radiochemical Centre) at pH 7.8; the labelled 3-methoxy-4-hydroxybenzoic acid so formed was extracted into ethylacetate after the reaction had been stopped with HCl.
Brain homogenate (10 /Ll) in plasma was assayed for MAO activity by the method of McCaman et al. (1965) . This involved oxidation of 5-hydroxy-[side chain-2-14C] tryptamine creatinine sulphate (Radiochemical Centre) at pH 7.2; the 5-hydroxy-indoleacetic acid so formed was extracted into ethyl acetate after the reaction had been stopped with HCl.
For both enzyme assays, activity was estimated from control brain homogenized in control plasma, and for control brain in jaundiced plasma.
RESULTS
The mean BUIs for blood background [11 3m
In] EDTA and [14C]noradrenaline uptake into brain beyond that of [11 3m In]EDTA are given in Ta ble 1. There is a small but very definite (p < 0.001) entry of noradrenaline into brain in both groups, but there was no significant effect of jaundice on either "blood background" or [J4C]noradren aline entry. Figure 1 records noradrenaline removal from the medium during incubation of homogenates of con trol brain in control plasma and of jaundiced brain in jaundiced plasma. There is a large decrease in rate of removal between 0 and 30 s, 4.3% of control for jaundiced brain and plasma. In Ta ble 2 are listed the p values for comparisons between the different experimental conditions and "pure" control. Jaun diced plasma with both control and jaundiced brains caused large and highly significant decreases of the rate of removal between 0 and 30 s, and smaller, less consistent reductions at 15 and 60 min. No sig nificant decrease occurred with jaundiced brain and control plasma. Values for COMT and MAO ac tivity in brain homogenates are given in Ta ble 3. Jaundiced plasma did not influence these enzymes significantly.
DISCUSSION
In a comprehensive study of the permeability of the blood-brain barrier by intracarotid injection, Oldendorf (1971) estimated BUIs in the rat for a number of neurotransmitter monoamines. They were uniformly low; the BUI of L-noradrenaline was 4.49% in the face of a mannitol background of 1.94% (i.e., a true extravascular uptake of 2.55%). Hardebo et al. (1977) and Hardebo and Nilsson (1979) have also measured BUIs for eH]-L-nor adrenaline, with [l4C]ethanol as the reference solute. Fifteen seconds after injection, the BUI for noradrenaline was 1. 7 -1. 9% after subtraction of a [ 3 H]inulin background. It would seem certain that there is a very small penetration of noradrenaline into or across the cerebral endothelium during a single capillary pass in the rat. Whereas the present results fully confirm this small uptake, they addi tionally prove that the permeability of the blood- The percentage radioactivity due to residual plasma, [l\3ffiInJEDTA plasma background, has been subtracted from the uncorrected BUI for noradrenaline to give actual uptake into brain tissue. bitartrate concentration was 1 f,lg ml-1. The two curves are for control brain plus control plasma (upper curve; triangles) and jaundiced brain plus jaundiced plasma (lower curve; squares).
brain barrier to noradrenaline is not increased in obstructive jaundice in the rat. Whether the small leak of noradrenaline occurs generally at the en dothelium of all cerebral vessels or is restricted to certain types or sizes of vessels (e.g., arterioles) is unknown. The experiments, in which a cellular homogenate of brain was incubated in the presence of blood plasma, clearly indicate that plasma from rats with obstructive jaundice contains an inhibitor which substantially and significantly diminishes the early removal of noradrenaline from the plasma medium by the suspended cellular or subcellular material or both. This inhibitor might be reducing the rate of removal of noradrenaline by an influence on one or more of a number of mechanisms. These comprise the various uptake and metabolic inactivating pro cesses. The former include neuronal uptake-! (Iversen, 1973) , which transports noradrenaline into noradrenergic presynaptic endings and which is presumably present both in noradrenergic nerves supplying cerebral blood vessels and in noradre nergic nerves within the brain parenchyma; and ex traneuronal uptake-2, which has different charac teristics, and transports noradrenaline into vascular smooth muscle, including, presumably, that of the cerebral arterioles (Fig. 2) . Additionally, it has been reported that the endothelial cells of the cerebral capillaries will accumulate noradrenaline if MAO is inhibited (Hardebo and Owman, 1980a) . This en ergy-dependent process has some characteristics of both the neuronal and extraneuronal processes. An other possible site for extraneuronal uptake is into glial cells (Hendley, 1976) . After uptake into cells, The specific experiment was always run simultaneously with a study of noradren aline removal in the presence of control brain homogenate and control plasma. Con ditions are as stated in legend to Fig. I ; P values are from analysis of variance for randomized block design.
noradrenaline may be incorporated into vesicles in neuronal endings, may be deaminated by MAO (a mitochondrial enzyme which is present in neu rones) in smooth muscle and in endothelial cells (Hardebo and Owman, 1980b) , or may be methyl ated by COMT, a cytoplasmic enzyme which is cer tainly present in smooth muscle but probably also occurs in cerebral parenchymal cells (Axelrod, 1971) .
The effect of jaundiced plasma on early removal of noradrenaline suggests that an inhibitor is acting on an uptake process rather than on the slower sub sequent metabolism of the amine. This is confirmed by the complete lack of effect of jaundiced plasma on specific assays for MAO and COMT in homog enates of brain. Which of the uptake mechanisms is being affected is uncertain. If jaundice is to allow noradrenaline to reach an effective concentration in the vicinity of cerebral smooth muscle, it seems most likely that it is the extraneuronal uptake-2 mechanism which is being influenced. Indeed, McCalden et al. (1977) found that infusion of a sub stance (a haloalkylamine GD13l) blocking extra neuronal uptake of noradrenaline would, like ob structive jaundice in the baboon, either abolish va- 12.5 ± 1.8 (6) Brain (0.1 g) was homogenized in either 2 ml of control plasma or in 2 ml of jaundiced plasma. Values are given as j.1g product h-1 g-l wet brain. Number of experiments in parentheses. sodilatation or convert it to a gamma receptor mediated vasoconstriction.
It is not yet known what the inhibitor or inhibitors of noradrenaline uptake in jaundiced plasma are. Among possible candidates are certain steroid hor mones and cholesterol. Several estrogens, gluco corticoids, and progesterone inhibit uptake-2 in rat heart and in arterial smooth muscle (Iversen and Salt, 1970; Nicol and Rae, 1972) . Cholesterol is an inhibitor of lower affinity (Salt and Iversen, 1972) but is present in plasma at an appropriately higher concentration. An investigation of these com pounds will also have to take into consideration the possibility of a change in the protein-binding of each in obstructive jaundice.
Since inhibition of an uptake mechanism by jaun diced plasma can be so clearly demonstrated in vitro, it is not unreasonable to suppose that the en hanced cerebrovascular sensitivity to intravascular noradrenaline observed by Bloom et al. (1975) is also due to inhibition of the same uptake mecha nism, allowing the small amount of noradrenaline that normally penetrates the blood-brain barrier to reach a high enough concentration to activate gamma receptors on the smooth muscle of cerebral arterioles. Because of the high lipid solubility of cholesterol and steroids, the blood-brain barrier would present no impediment to access of these potential inhibitors.
